Market Insights Health Hospitals Inpatient Care

Neoplasm Treatment - Kenya

Kenya

The Neoplasm Treatment market in Kenya is expected to witness significant growth in the coming years.
According to projections, the revenue in this market is estimated to reach US$225.60m by 2024.
Furthermore, it is anticipated that the market will experience an annual growth rate of 5.09% between 2024 and 2029, leading to a market volume of US$289.20m by 2029.
When compared to other countries, in the United States is predicted to generate the highest revenue in the Neoplasm Treatment market, with a projected revenue of US$90.56bn in 2024.
Kenya's neoplasm treatment market is witnessing a surge in demand for advanced radiation therapy techniques.

Key regions: India, Japan, United States, United Kingdom, Germany

Market

Region

Region comparison

Currency

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on revenue received by hospitals from public or private sources, allocated to the country where the money is spent, including VAT if applicable.

Modeling approach / Market size:

Market sizes are determined by a bottom-up approach, based on a specific rationale for each market market. Next, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, public health spend, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.